Rep. Lisa C. McClain Buys West Pharmaceutical Services, Inc. (NYSE:WST) Shares

Representative Lisa C. McClain (R-Michigan) recently bought shares of West Pharmaceutical Services, Inc. (NYSE:WST). In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in West Pharmaceutical Services stock on June 17th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Autoliv (NYSE:ALV) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of XPO (NYSE:XPO) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Lithia Motors (NYSE:LAD) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Sanofi (NASDAQ:SNY) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Group 1 Automotive (NYSE:GPI) on 7/22/2025.

West Pharmaceutical Services Price Performance

NYSE:WST opened at $245.9920 on Thursday. West Pharmaceutical Services, Inc. has a 52 week low of $187.43 and a 52 week high of $352.33. The company has a quick ratio of 2.08, a current ratio of 2.78 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $17.69 billion, a PE ratio of 36.83, a price-to-earnings-growth ratio of 4.38 and a beta of 1.05. The stock’s 50-day moving average price is $231.28 and its 200-day moving average price is $227.36.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 24th. The medical instruments supplier reported $1.84 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.33. West Pharmaceutical Services had a return on equity of 18.43% and a net margin of 16.48%.The firm had revenue of $766.50 million for the quarter, compared to analysts’ expectations of $725.11 million. During the same period last year, the firm earned $1.52 EPS. The company’s quarterly revenue was up 9.2% on a year-over-year basis. West Pharmaceutical Services has set its FY 2025 guidance at 6.650-6.850 EPS. As a group, equities analysts expect that West Pharmaceutical Services, Inc. will post 6.62 EPS for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 19th. Stockholders of record on Wednesday, November 12th will be given a dividend of $0.22 per share. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, November 12th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.4%. West Pharmaceutical Services’s payout ratio is 12.57%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of WST. Boston Trust Walden Corp raised its holdings in West Pharmaceutical Services by 4.7% during the first quarter. Boston Trust Walden Corp now owns 1,110 shares of the medical instruments supplier’s stock worth $249,000 after purchasing an additional 50 shares in the last quarter. SYM FINANCIAL Corp raised its holdings in West Pharmaceutical Services by 5.1% during the second quarter. SYM FINANCIAL Corp now owns 1,027 shares of the medical instruments supplier’s stock worth $225,000 after purchasing an additional 50 shares in the last quarter. Benjamin Edwards Inc. raised its holdings in West Pharmaceutical Services by 1.7% during the second quarter. Benjamin Edwards Inc. now owns 3,021 shares of the medical instruments supplier’s stock worth $661,000 after purchasing an additional 50 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in West Pharmaceutical Services by 4.0% during the second quarter. Parkside Financial Bank & Trust now owns 1,318 shares of the medical instruments supplier’s stock worth $288,000 after purchasing an additional 51 shares in the last quarter. Finally, MJP Associates Inc. ADV grew its position in West Pharmaceutical Services by 2.7% during the second quarter. MJP Associates Inc. ADV now owns 1,970 shares of the medical instruments supplier’s stock worth $431,000 after buying an additional 52 shares during the period. 93.90% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on WST. Citigroup reiterated a “buy” rating on shares of West Pharmaceutical Services in a report on Thursday, May 22nd. Barclays began coverage on West Pharmaceutical Services in a report on Tuesday, June 24th. They issued an “equal weight” rating and a $245.00 price objective on the stock. Evercore ISI lifted their price objective on West Pharmaceutical Services from $275.00 to $350.00 and gave the stock an “outperform” rating in a report on Friday, July 25th. Wall Street Zen upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Finally, UBS Group lifted their price objective on West Pharmaceutical Services from $285.00 to $320.00 and gave the stock a “buy” rating in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $320.71.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.